Click to zoom
Product Description
Treatment Advanced Breast Cancer
Packaging Type Vial
Strength 250 mg
Storage Condition in a refrigerator at 2°C to 8°C (36°F to 46°F)
Shelf Life 24 months
Country of Origin Made in India
Manufacturer Natco
Packaging Size 1 Vial
Brand Fulvenat
Composition Fulvestrant Injection IP
Minimum order quantity: 50 Vial
Fulvenat (Fulvestrant) 250 mg Injection is a prescription medication used to treat hormone receptor-positive advanced breast cancer in postmenopausal women. Manufactured by Natco Pharma, it acts as an estrogen blocker to slow tumor growth. It is administered by a healthcare professional via a slow intramuscular injection.
liketo,usa.uk.china.southkorea.russia.japan.singapore
Composition
Composition details not available.
Shipping Information
We offer reliable delivery across India and international markets. Domestic orders are typically delivered within 5-7 business days. International shipping times vary by destination. All orders are carefully packaged to maintain product integrity.
100 mg MASTARIX Drostanolone Propionate Injection
On Request
Dapzigard-s 50 Dapagliflozin 10 mg & Sitagliptin 50 mg Tablets
On Request
100 mg Reditux 100 Rituximab Injection
On Request
420 mg Womab Pertuzumab Injection
On Request
50 mg AMBILON 50 Amphotericin B Liposome Injection
On Request
50 mg Qulip Liposomal Amphotericin B Injection
On Request
500 mg LupiximAb 500 Rituximab Injection
On Request
2 mg SAMRUCIN PL Doxorubicin Hydrochloride Liposomal Injection
On Request